Quick Answer
DuPont de Nemours, Inc. reported Research And Development Expense of $193.00 million for the year ending 2025.
- DuPont de Nemours, Inc. showed a decrease of -4.9% in Research And Development Expense from 2024 to 2025.
- This data is from DuPont de Nemours, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: $399.00 million | Q1 2017: $419.00 million | Q2 2017: $408.00 million | Q3 2017: $528.00 million | Q1 2018: $768.00 million | Q2 2018: $270.00 million | Q3 2018: $264.00 million | Q1 2019: $267.00 million | Q2 2019: $232.00 million | Q3 2019: $225.00 million | Q1 2020: $173.00 million | Q2 2020: $153.00 million | Q3 2020: $140.00 million | Q1 2021: $139.00 million | Q2 2021: $133.00 million | Q3 2021: $137.00 million | Q1 2022: $143.00 million | Q2 2022: $141.00 million | Q3 2022: $129.00 million | Q1 2023: $127.00 million | Q2 2023: $125.00 million | Q3 2023: $128.00 million | Q1 2024: $125.00 million | Q2 2024: $134.00 million | Q3 2024: $127.00 million | Q1 2025: $137.00 million | Q2 2025: $142.00 million | Q3 2025: $140.00 million.
- Over the full 11 years of available data (2015 to 2025), DuPont de Nemours, Inc.'s Research And Development Expense has declined by 87.9%.
- Historical annual values: Fiscal year 2025: $193.00 million | Fiscal year 2024: $203.00 million | Fiscal year 2023: $192.00 million | Fiscal year 2022: $536.00 million | Fiscal year 2021: $557.00 million | Fiscal year 2020: $565.00 million | Fiscal year 2019: $689.00 million | Fiscal year 2018: $1.07 billion | Fiscal year 2017: $657.00 million | Fiscal year 2016: $1.59 billion | Fiscal year 2015: $1.60 billion.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: